Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ZEN-3694 |
Synonyms | |
Therapy Description |
ZEN-3694 is a pan BET inhibitor that suppresses AR signaling, which potentially inhibits tumor progression (Cancer Res 2016;76(14 Suppl):Abstract nr LB-207, PMID: 32694156). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ZEN-3694 | ZEN003694|BETi ZEN-3694|ZEN3694|ZEN 3694 | BET Inhibitor (Pan) 32 | ZEN-3694 is a pan BET inhibitor that suppresses AR signaling, which potentially inhibits tumor progression (Cancer Res 2016;76(14 Suppl):Abstract nr LB-207, PMID: 32694156). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02705469 | Phase I | ZEN-3694 | A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer | Completed | USA | 0 |
NCT05607108 | Phase II | ZEN-3694 | A Study of ZEN003694 in People With Squamous Cell Lung Cancer | Recruiting | USA | 0 |